Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/04/224
Active ingredient: Homoharringtonine
Indication: Treatment of chronic myeloid leukaemia
Sponsor: Teva Pharma GmbH
Graf-Arco-Straße 3, 89079 Ulm, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/09/2004 Orphan designation EMEA/OD/041/04 (2004)3426 of 02/09/2004
25/11/2008 Change of name and/or address of sponsor
08/01/2009 Transfer of orphan designation EMEA/OD/041/04/T/01 (2009)19 of 05/01/2009
13/12/2012 Transfer of orphan designation EMEA/OD/041/04/T/02 (2012)9405 of 06/12/2012
27/04/2016 Removal of orphan designation from Community Register